On behalf of the Company, the
undersigned respectfully requests withdrawal of the above-referenced
Post-Effective Amendment No. 1 to Form S-1 that was filed with the Securities
and Exchange Commission on April 14, 2009 (the “Post-Effective
Amendment”).
In accordance with Rule 477
promulgated pursuant to the Securities Act of 1933, as amended, the undersigned
confirms that no securities of the Company were sold pursuant to the
Post-Effective Amendment. Effectiveness of the Post-Effective Amendment has not
been granted. The grounds on which the Company makes this application are that
there is no longer any intention to offer or sell securities under the
Post-Effective Amendment.
Sincerely,
Arno Therapeutics,
Inc.
By:
/s/ Brian
Lenz
Brian
Lenz
Chief
Financial Officer
Dates Referenced Herein and Documents Incorporated by Reference
